Paragon Sports Medicine

Vitamin C IV Therapy in Atlanta

Vitamin C (ascorbic acid) is an essential water-soluble vitamin and antioxidant. Intravenous administration achieves much higher blood levels than oral supplementation.

Vitamin C has a role in immune cell function, antioxidant recycling and collagen formation. Evidence for general wellness benefit from IV vitamin C is limited.

Overview

Vitamin C exists primarily as ascorbic acid (reduced form) and dehydroascorbic acid (oxidized form), with these forms interconverting based on cellular redox conditions. The molecule's structure contains two ionizable hydroxyl groups that donate electrons, enabling its antioxidant function. Humans cannot synthesize vitamin C due to loss of the L-gulonolactone oxidase enzyme, making it an essential dietary nutrient.

At physiological pH, vitamin C exists predominantly as ascorbate anion. The compound's ability to donate electrons while remaining relatively stable makes it an ideal antioxidant and reducing agent. Its water solubility allows rapid distribution throughout aqueous body compartments following IV administration.

Patient consulting with Dr. Ched Garten at Paragon, symbolizing advanced non-surgical care for joint, tendon, muscle, and pain issues.

Chemical structure & Properties

  • Molecular Formula: C₆H₈O₆
  • Molecular Weight: 176.12 g/mol
  • Chemical Name: L-Ascorbic acid
  • Chemical Class: Water-soluble vitamin, lactone
  • pH: Acidic (approximately 2.1-2.6 in solution)
  • Stability: Sensitive to heat, light, and oxygen; requires proper storage

Mechanism of Action

Antioxidant and Pro-oxidant Properties

  • Directly scavenges reactive oxygen species (ROS) including superoxide, hydroxyl radicals, and singlet oxygen
  • May help protect cellular proteins, lipids, and DNA from oxidative damage
  • May help regenerate other antioxidants, including vitamin E and glutathione
  • At high concentrations (achievable only via IV), generates hydrogen peroxide in extracellular fluid
  • May help reduce oxidative stress markers

Immune Function

  • May support neutrophil function, including chemotaxis and phagocytosis
  • May support natural killer cell activity
  • May support lymphocyte proliferation and differentiation
  • May support antibody production and immune response
  • May help protect immune cells from oxidative stress
  • Accumulates in phagocytic cells at concentrations 50-100 times higher than plasma
  • May reduce duration and severity of infections

Collagen Synthesis and Tissue Repair

  • Essential cofactor for prolyl hydroxylase and lysyl hydroxylase enzymes
  • Required for collagen triple helix stabilization
  • Plays a role in the body's natural wound healing and tissue repair
  • May support blood vessel integrity and skin health
  • Necessary for bone, cartilage, and connective tissue formation
  • May support healing and recovery after surgery

Enzymatic Cofactor Functions

  • Required cofactor for dopamine beta-hydroxylase (norepinephrine synthesis)
  • Supports carnitine production, which is involved in fatty acid metabolism
  • Necessary for tyrosine metabolism
  • Plays a role in the synthesis of neuropeptides and hormones
  • Helps the body absorb iron by keeping it in its reduced ferrous form
  • Facilitates numerous hydroxylation reactions throughout the body

Cardiovascular Support

  • May support endothelial function and nitric oxide availability
  • May help reduce oxidation of LDL cholesterol
  • May support blood vessel elasticity and integrity
  • May help regulate blood pressure
  • May support healthy endothelial function

Dose Considerations: Dosing is set by your provider based on your history, screening results and baseline vitamin C status.

Safety Profile and Considerations

Clinical Safety

Vitamin C IV therapy is generally well tolerated with appropriate patient selection and screening. Its water-soluble nature allows excess to be excreted through the kidneys.

Potential Side Effects

Common (Generally Mild):

  • Vein irritation or burning at injection site (due to acidity)
  • Mild nausea or gastrointestinal discomfort
  • Transient fatigue during or immediately after high-dose infusion
  • Mild diuretic effect and increased urination
  • Thirst
  • Lightheadedness (usually resolves during infusion)

Uncommon:

  • Headache
  • Flushing
  • Dizziness
  • Chills or sensation of cold

Rare but Important:

  • Kidney stone formation (in susceptible individuals with high-dose repeated use)
  • Hemolytic anemia in G6PD-deficient patients (can be severe)
  • Significant vein irritation or phlebitis
  • Hypoglycemia (rare, more common at very high doses)

Management: Slower infusion rates reduce irritation and discomfort. Adequate hydration before and after treatment improves tolerance. Most side effects resolve quickly after infusion or with rate adjustment.

Critical Precautions

  • Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency: ABSOLUTE CONTRAINDICATION at high doses. High-dose vitamin C can trigger severe hemolytic anemia in G6PD-deficient individuals, potentially life-threatening. Screen patients before administration when deficiency is suspected (African, Mediterranean, Asian descent or family history).
  • Renal Disease: Use with extreme caution or avoid in kidney disease. Vitamin C is renally excreted and metabolized to oxalate. Patients with renal impairment risk accumulation, oxalate nephropathy, and kidney stone formation. Generally contraindicated in severe renal insufficiency.
  • Kidney Stone History: Increased risk of calcium oxalate stone formation with repeated high-dose administration. Careful assessment and monitoring required. Adequate hydration is essential.
  • Iron Overload Disorders: Vitamin C enhances iron absorption and mobilization. Use with caution in hemochromatosis or iron overload conditions.
  • Pregnancy and Lactation: Generally avoided due to limited safety data at high doses. Physiological doses may be appropriate under obstetric guidance.

Contraindications

  • Known G6PD deficiency (absolute contraindication for high doses)
  • Severe renal impairment or renal failure
  • Active kidney stones or strong history of calcium oxalate stones
  • Hemochromatosis or iron overload disorders
  • Pregnancy and breastfeeding (for high-dose therapy)
  • Known hypersensitivity to vitamin C or formulation components

Drug Interactions

  • Warfarin: High-dose vitamin C may affect INR. Monitor anticoagulation more frequently.
  • Aspirin and NSAIDs: May increase gastrointestinal effects when combined.
  • Oral Contraceptives: May increase estrogen levels slightly.
  • Aluminum-Containing Antacids: Vitamin C increases aluminum absorption; avoid combination.

Laboratory Interference

High-dose vitamin C can cause false-positive or false-negative results in certain laboratory tests including glucose monitoring (falsely low readings on some glucometers), stool occult blood testing (false-positive), and serum glucose laboratory tests (interference possible). Inform healthcare providers and laboratory personnel of recent high-dose vitamin C administration.

Monitoring Requirements

  • Pre-treatment G6PD screening when indicated by ethnicity or family history
  • Renal function assessment (creatinine, eGFR)
  • Kidney stone history evaluation
  • Blood glucose monitoring during high-dose infusions (diabetic patients)
  • Hydration status assessment

Regulatory Status and

Clinical Use

FDA Status

Vitamin C is an approved vitamin and dietary supplement; high-dose IV use for disease treatment represents off-label application

Clinical Use

Used off-label by healthcare providers

Compounding Status

Available through pharmacies and compounding facilities in various concentrations

Quality Considerations:

Pharmaceutical-grade ascorbic acid required; proper pH buffering important for tolerability

High-dose IV vitamin C therapy represents off-label use based on established physiological roles, emerging clinical evidence, decades of clinical experience in integrative medicine, and growing research support.

Clinical Considerations

The Paragon Method: Step-by-Step

Administration and Treatment

  • Route: Intravenous infusion over extended period for high doses
  • Infusion Rate: Typically 0.5-1.0 g per minute; slower rates improve tolerance
  • Duration: 30 minutes to 3+ hours depending on dose (higher doses require longer infusion times)
  • Frequency: Set by your provider based on your history, screening and response
  • Hydration: Adequate hydration before and after treatment essential
Woman meditating cross-legged on a yoga mat in a sunlit room with eyes closed.

Patient Selection

Appropriate candidates are determined at a clinical evaluation, including a full medication review.

Woman meditating cross-legged on a yoga mat in a sunlit room with eyes closed.

Pre-Treatment Assessment

  • Comprehensive medical history including kidney disease and stone history
  • G6PD screening when indicated by ethnicity or family history
  • Renal function evaluation (creatinine, eGFR)
  • Current medications review
  • Iron status assessment if concerns for overload
  • Baseline symptom and functional status documentation
  • Informed consent discussing off-label use and dose-specific considerations
Woman meditating cross-legged on a yoga mat in a sunlit room with eyes closed.

Optimization Strategies

  • Adequate hydration 1-2 hours before treatment (16-32 oz water)
  • Light meal before high-dose infusions to prevent hypoglycemia
  • Calcium and magnesium co-administration may reduce side effects
  • Slower infusion rates for first treatment to assess tolerance
  • Continued hydration after treatment to support renal excretion
  • Regular session schedules based on your goals and provider guidance
  • Avoidance of NAD+-depleting substances (excessive alcohol, smoking)
Woman meditating cross-legged on a yoga mat in a sunlit room with eyes closed.

During Infusion Management

  • Vital signs monitoring at start and intervals during high-dose infusions
  • Patient comfort assessment and communication
  • Rate adjustment based on tolerance
  • Blood glucose monitoring in diabetic patients during very high doses
  • Vein site monitoring for irritation
  • Vein site monitoring for irritation
Woman meditating cross-legged on a yoga mat in a sunlit room with eyes closed.

Post-Treatment Care

  • Observation period after infusion completion
  • Hydration encouragement (16-24 oz water)
  • Assessment of immediate response and side effects
  • Education about potential temporary fatigue followed by energy increase
  • Discussion of what to expect after treatment
  • Scheduling of follow-up treatments based on protocol
  • Scheduling of follow-up treatments based on protocol
Woman meditating cross-legged on a yoga mat in a sunlit room with eyes closed.

Monitoring

  • Session-by-session tolerance assessment
  • Progressive evaluation of response and tolerability
  • Periodic renal function monitoring with regular high-dose therapy
  • Long-term wellness parameter tracking
Woman meditating cross-legged on a yoga mat in a sunlit room with eyes closed.
Man seated indoors with a soccer ball in natural light, representing Paragon’s musculoskeletal recovery expertise and regenerative treatment focus.

Conclusion

Vitamin C IV therapy delivers vitamin C directly into the bloodstream, after a provider review and safety screening, including G6PD testing.

Evidence for general wellness benefit is limited. Whether it is appropriate for you is a clinical decision made after evaluation.

References

Carr AC, Maggini S. Vitamin C and immune function. Nutrients. 2017;9(11):1211.

Fritz H, et al. Intravenous vitamin C and cancer: A systematic review. Integr Cancer Ther. 2014;13(4):280-300.

Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013;2013(1):CD000980.

Fowler AA, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure. JAMA. 2019;322(13):1261-1270.

Padayatty SJ, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140(7):533-537.

Levine M, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci USA. 1996;93(7):3704-3709.

Chen Q, et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA. 2005;102(38):13604-13609.

Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. While vitamin C is an essential nutrient and approved vitamin, high-dose IV administration for disease treatment represents off-label use not approved by the FDA. Patients should consult with qualified healthcare providers before considering any IV therapy. G6PD screening is essential before high-dose administration. The content reflects current scientific literature and clinical practice as of 2025. Individual results may vary, and treatment appropriateness should be determined on a case-by-case basis by licensed medical professionals. This therapy should only be administered by trained healthcare providers with appropriate screening, monitoring, and emergency preparedness.